Bank Of America Corp Calliditas Therapeutics Ab Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$17.65 - $41.41 $6,812 - $15,984	-386 Reduced 37.04%	656 $25,000
Q1 2024 May 15, 2024	BUY	$20.04 - $25.66 $14,609 - $18,706	729 Added 232.91%	1,042 $21,000
Q4 2023 Feb 14, 2024	SELL	$15.79 - $28.99 $31 - $57	-2 Reduced 0.63%	313 $8,000
Q2 2023 Aug 14, 2023	BUY	$15.7 - $25.61 $298 - $486	19 Added 6.42%	315 $4,000
Q1 2023 May 12, 2023	BUY	$16.8 - $25.24 $1,478 - $2,221	88 Added 42.31%	296 $7,000
Q4 2022 Feb 10, 2023	BUY	$11.5 - $19.6 $2,392 - $4,076	208 New	208 $3,000
Q2 2022 Aug 12, 2022	SELL	$12.85 - $20.36 $7,568 - $11,992	-589 Reduced 73.44%	213 $3,000
Q1 2022 May 16, 2022	SELL	$15.14 - $25.55 $7,539 - $12,723	-498 Reduced 38.31%	802 $16,000
Q4 2021 Feb 08, 2022	BUY	$15.04 - $26.32 $16,649 - $29,136	1,107 Added 573.58%	1,300 $32,000
Q3 2021 Nov 15, 2021	BUY	$21.03 - $33.19 $4,058 - $6,405	193 New	193 $4,000

1.84K

Ticker CALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,624,800
Market Cap $1.06B
Description
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.